Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Receptor for neuropeptide Y and peptide YY. Additionally we are shipping NPY5R Kits (17) and NPY5R Proteins (7) and many more products for this protein.
Showing 10 out of 81 products:
Human Polyclonal NPY5R Primary Antibody for EIA, WB - ABIN493173
Magni: Hormonal control of the neuropeptide Y system. in Current protein & peptide science 2003
Show all 5 references for ABIN493173
Human Polyclonal NPY5R Primary Antibody for IHC (p), IHC - ABIN250423
Badman, Flier: The gut and energy balance: visceral allies in the obesity wars. in Science (New York, N.Y.) 2005
Show all 4 references for ABIN250423
Human Polyclonal NPY5R Primary Antibody for IF, IHC - ABIN1535790
Gerald, Walker, Criscione, Gustafson, Batzl-Hartmann, Smith, Vaysse, Durkin, Laz, Linemeyer, Schaffhauser, Whitebread, Hofbauer, Taber, Branchek, Weinshank: A receptor subtype involved in neuropeptide-Y-induced food intake. in Nature 1996
Show all 2 references for ABIN1535790
Human Polyclonal NPY5R Primary Antibody for IHC, ELISA - ABIN185409
Sheriff, Ali, Yahya, Haider, Balasubramaniam, Amlal: Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. in Molecular cancer research : MCR 2010
Show all 2 references for ABIN185409
Human Polyclonal NPY5R Primary Antibody for ICC, IF - ABIN314726
Czarnecka, Trinh, Lu, Kuan-Celarier, Galli, Hong, Tilan, Talisman, Izycka-Swieszewska, Tsuei, Yang, Martin, Horton, Christian, Everhart, Maheswaran, Kitlinska: Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance. in Oncogene 2015
Lower mRNA levels of neuropeptide Y (show NPY Antibodies) receptor 1 (NPY1R (show NPY1R Antibodies)) and NPY5R but not NPY (show NPY Antibodies) or NPY2R (show NPY2R Antibodies) in the central nucleus of the amygdala predicted elevated anxious temperament.
The objectives of this study were to identify single nucleotide polymorphisms in the bovine NPY5R gene.
NPY5R is an inducible pro-survival factor that is responsible for chemoresistance in neuroblastoma (show ARHGEF16 Antibodies) cells.
Variations in genes AGRP (show AGRP Antibodies), CPE (show CPE Antibodies), GHRL (show GHRL Antibodies), GLP1R (show GLP1R Antibodies), HTR2A (show HTR2A Antibodies), NPY1R (show NPY1R Antibodies), NPY5R, SOCS3 (show SOCS3 Antibodies) and STAT3 (show STAT3 Antibodies) showed modest associations with BMI in European Americans.
these data highlight a novel mechanism by which NPY (show NPY Antibodies) may promote breast cancer progression, and further implicate a pathological role of the NPY (show NPY Antibodies) Y5R.
Together, our results suggest that Y5R plays an important role in cancer cell growth and migration and could be a novel therapeutic target for breast cancer.
NPY1R (show NPY1R Antibodies) and NPY5R have roles in nutrient-specific food intake in Europeans
The authenticity of this transcript was confirmed by isolating part of its 5'UTR (show UTS2R Antibodies) and analysing its tissue distribution,, we have shown that the two AUG triplets contained in the 5' untranslated region of Y5(L) mRNA did not affect receptor expression
Neuropeptide-Y (show NPY Antibodies) induced endothelial cell migration was mimicked by agonists and fully blocked by antagonists for any specific NPY (show NPY Antibodies) receptor (NPY5R).
single nucleotide polymorphisms in the NPY5R gene may have a role in dyslipidemia (elevated triglyceride concentrations and reduced high-density lipoprotein levels) in Mexican Americans
Sequence variations in neuropeptide Y (show NPY Antibodies) receptor genes (NPY5R and NPY2R (show NPY2R Antibodies)) are associated with alcohol dependence, cocaine dependence, and comorbid alcohol and cocaine dependence.
Results suggest that rabbit and human Y1, Y2 and Y5 receptor subtypes are well conserved, whereas Y4 receptors are less well conserved.
Npy1r (show NPY1R Antibodies)(Y5R-/-) mice show increased anxiety-related behavior but no changes in hypothalamus-pituitary-adrenocortical axis activity or in body weight growth, independently of gender and mouse strain used as foster mothers. Also, Npy1r (show NPY1R Antibodies)(Y5R-/-) mice of both genders display increased spatial reference memory in the Morris water maze test.
Study shows pronounced adaptive changes in the mouse hippocampus both with regard to NPY (show NPY Antibodies) synthesis and NPY (show NPY Antibodies) receptor synthesis and binding, which may contribute to regulating neuronal seizure susceptibility after kainate
The Y5 receptor subtype, previously believed to mediate food intake, plays a critical role in modulation of hippocampal excitatory transmission at the hilar-to-CA3 (show CA3 Antibodies) synapse in the mouse
biological redundancies between Y1 and Y5 receptor signaling in the NPY (show NPY Antibodies)-mediated control of food intake.
A limited distribution of Y5R expression is found in the hypothalamus; this receptor may be involved primarily in feeding and body weight control via neuropeptide Y's action on proopiomelanocortin (show POMC Antibodies)-expressing neurons.
Results indicate that the NPY Y5 receptor Y5R is involved in the regulation and development of diet-induced obesity and suggest utility for Y5R antagonists in the treatment of obesity.
Npy5r antagonist-treated mice showed an up-regulation of uncoupling protein (show UCP3 Antibodies) mRNA in brown adipose tissue (BAT (show BAAT Antibodies)) and white adipose tissue (WAT), suggesting that both BAT (show BAAT Antibodies) and WAT contribute to energy expenditure.
Show that spironolactone Y5 receptor antagonist has potent antiobesity effects in obese mice.
Feeding behavior and gene expression of appetite-related neuropeptides in mice lacking for neuropeptide Y (show NPY Antibodies) Y5 receptor subclass.
These findings confirm an interaction between neuropeptide Y (show NPY Antibodies)(1) and Y(5) receptors in the regulation of energy homeostasis.
Receptor for neuropeptide Y and peptide YY. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity. Seems to be associated with food intake. Could be involved in feeding disorders (By similarity).
neuropeptide Y receptor type 5
, neuropeptide Y receptor Y5
, neuropeptide Y receptor type 5-like
, NPY Y5
, NPY-Y5 receptor
, Y5 receptor
, neuropeptide Y5 receptor
, Neuropeptide Y5 receptor
, G-protein coupled receptor
, NPY receptor 5